Skip to content

Target trial emulation of first-line ribociclib versus palbociclib in hormone receptor-positive, HER2-negative metastatic breast cancer: a comparative effectiveness study

Oct 2026 · Breast Cancer · Vol 33, pp. 1419 - 1432 · 0 citations · 39 references
Medicine
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.